J. Lipid Res. Neurobiology of Lipids (ISSN1683-5506)
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1194/jlr.M400453-JLR200 on June 1, 2005

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
M400453-JLR200v1
46/8/1633    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gnerre, C.
Right arrow Articles by Meyer, U. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gnerre, C.
Right arrow Articles by Meyer, U. A.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Journal of Lipid Research, Vol. 46, 1633-1642, August 2005
Copyright © 2005 by American Society for Biochemistry and Molecular Biology

LXR deficiency and cholesterol feeding affect the expression and phenobarbital-mediated induction of cytochromes P450 in mouse liver

Carmela Gnerre1,*, Gertrud U. Schuster{dagger}, Adrian Roth*, Christoph Handschin§, Lisen Johansson{dagger},**, Renate Looser*, Paolo Parini{dagger},**, Michael Podvinec*, Kirsten Robertsson{dagger}, Jan-Åke Gustafsson{dagger} and Urs A. Meyer2,*

* Division of Pharmacology/Neurobiology, Biozentrum of the University of Basel, CH-4056 Basel, Switzerland
{dagger} Department of Biosciences at Novum, Karolinska Institutet, S-141 57 Huddinge, Sweden
§ Department of Cancer Biology, Dana-Farber Cancer Institute, and Department of Cell Biology, Harvard Medical School, Boston, MA 02115
** Metabolism Unit, Center for Metabolism and Endocrinology, Department of Medicine, Novum, Karolinska Institutet at Huddinge University Hospital, S-141 86 Stockholm, Sweden

Published, JLR Papers in Press, June 1, 2005. DOI 10.1194/jlr.M400453-JLR200

1 Present address of C. Gnerre: Actelion Pharmaceuticals Ltd., CH-4123 Allschwil, Switzerland.

2 To whom correspondence should be addressed. e-mail: urs-a.meyer{at}unibas.ch

Metabolic transformation by the superfamily of cytochromes P450 (CYPs) plays an important role in the detoxification of xenobiotics such as drugs, environmental pollutants, and food additives. Endogenous substrates of CYPs include fatty acids, sterols, steroids, and bile acids. Induction of CYPs via transcriptional activation by substrates and other xenobiotics is an important adaptive mechanism that increases the organism's defense capability against toxicity. Numerous in vivo and in vitro data have highlighted the concept that the molecular mechanism of hepatic drug induction is linked to endogenous regulatory pathways. In particular, in vitro data suggest that oxysterols via the liver X receptor (LXR) inhibit phenobarbital (PB)-mediated induction of CYPs. To study the link between LXR, cholesterol homeostasis, and drug induction in vivo, we designed experiments in wild-type, LXR{alpha}-, LXRß-, and LXR{alpha}/ß-deficient mice. Our data expose differential regulatory patterns for Cyp2b10 and Cyp3a11 dependent on the expression of LXR isoforms and on challenge of cholesterol homeostasis by excess dietary cholesterol.

Our results suggest that, in the mouse, liver cholesterol status significantly alters the pattern of expression of Cyp3a11, whereas the absence of LXR leads to an increase in PB-mediated activation of Cyp2b10.

Abbreviations: CAR, constitutive androstane receptor; CYP, cytochrome P450; CYP7A1, cholesterol 7{alpha}-hydroxylase; DR4, direct repeat separated by four nucleotides; FXR, farnesoid X receptor; LXR, liver X receptor; MRP3, multidrug resistance-associated protein 3; PB, phenobarbital; PBRU, phenobarbital-responsive enhancer unit; PCN, pregnenolone 16{alpha}-carbonitrile; PXR, pregnane X receptor; SREBP-1c, sterol-regulatory element binding protein 1c; TG, triglyceride; XREM, xenobiotic-responsive enhancer module

Supplementary key words liver X receptor • pregnane X receptor • constitutive androstane receptor • metabolism • cytochrome P450 3a11 • cytochrome P450 2b10


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Mol. Endocrinol.Home page
H. Gong, P. Guo, Y. Zhai, J. Zhou, H. Uppal, M. J. Jarzynka, W.-C. Song, S.-Y. Cheng, and W. Xie
Estrogen Deprivation and Inhibition of Breast Cancer Growth in Vivo through Activation of the Orphan Nuclear Receptor Liver X Receptor
Mol. Endocrinol., August 1, 2007; 21(8): 1781 - 1790.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. W. Joyce, E. M. Wagner, F. Basso, M. J. Amar, L. A. Freeman, R. D. Shamburek, C. L. Knapper, J. Syed, J. Wu, B. L. Vaisman, et al.
ABCA1 Overexpression in the Liver of LDLr-KO Mice Leads to Accumulation of Pro-atherogenic Lipoproteins and Enhanced Atherosclerosis
J. Biol. Chem., November 3, 2006; 281(44): 33053 - 33065.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.